Group 6 Copy 257
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Working towards a low-cost ostomy bag that doesn't leak

    Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

    Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

    An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

    Why does our body produce one of the most potent hallucinogens?

    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings...

    Backer Badge Funded